BridgeBio has substantially boosted this course of the innovative treatment for amyloid heart disease, leveraging Attruby. Initial clinical results reveals potential improvements for individuals diagnosed from a https://biotech419304.blogmazing.com/40909852/company-advances-cardiac-amyloidosis-therapy-through-the-drug